Evidence map›Paper›PMID 41605498›Full record

ArticleJournal of medical Internet research2026

Characteristics Influencing Support for the National Health Service COVID-19 App in England and Wales: Findings From a Longitudinal Survey.

Josephine Exley, Paul Boadu, Kasim Allel, Bob Erens, Nicholas Mays, Mustafa Al-Haboubi

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Josephine ExleyLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0002-6501-0854
Paul BoaduLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0001-9712-4760
Kasim AllelNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-2144-7181
Bob ErensLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0002-4430-954X
Nicholas MaysLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0001-9808-8466
Mustafa Al-HaboubiLondon School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID https://orcid.org/0000-0001-9847-2206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of proximity (contact) tracing mobile phone apps during the COVID-19 pandemic to support manual contact tracing was novel. Uptake of the app was lower than expected.

objectiveWe sought to identify distinct subgroups of individuals based on their level of support for the National Health Service (NHS) COVID-19 app in the first 15 months of the app's implementation, and to identify the attitudes and characteristics associated with membership of more and less supportive groups.

methodsWe conducted 8 waves of a longitudinal survey data of smartphone users, recruited from an online panel (n=2023 at baseline and n=1198 at survey wave 6) between October 14, 2020, and December 13, 2021. We used latent class analysis to identify subgroups of individuals with different inclinations of support for the NHS COVID-19 app. Sankey diagram analysis was used to assess individuals whose subgroup changed over the study period. We estimated population-weighted multinomial logistic regression models using sociodemographic characteristics as independent variables.

resultsWe identified 4 subgroups in survey waves 1 to 4-"not supportive" (1765/7210, 25%), "ambivalent" (2124/7210, 30%), "somewhat supportive" (1421/7219, 20%), and "completely supportive" (1900/7210, 26%). At wave 5, a total of 3 subgroups of support for the app emerged-"not supportive" (549/1613, 34%), "ambivalent" (497/1613, 31%), and "supportive" (567/1613, 35%). From wave 6 onward, the results showed 4 subgroups emerging-"least supportive" (1568/6952, 23%), "less supportive" (1179/6952, 17%), "ambivalent" (2105/6952, 30%), and "supportive" (2100/6952, 29%). The majority of respondents remained within their identified subgroups between survey waves. Among those who moved into different subgroups, most moved into a less supportive subgroup. Exceptions to this were from waves 2 to 3 and from waves 3 to 4, when higher percentages of respondents moved into more supportive subgroups. The biggest movement to less supportive subgroups occurred after wave 1 (October 2020), when 38% (2740/7210) of respondents moved into a less supportive subgroup. The biggest movement to more supportive subgroups, on the other hand, occurred after wave 2, when 22% (1586/7210) of respondents moved into more supportive subgroups. Over the course of the 8 waves, the percentage of respondents in supportive subgroups declined from 56% (3353/5988) to 29% (1737/5988). Key characteristics of more supportive individuals included having higher levels of trust in the government to control the spread of COVID-19 and having the app installed, while those less concerned about the risk COVID-19 posed to the country were more likely to be unsupportive (P<.05).

conclusionsWhen the app was launched, just over half of respondents were supportive, but this declined over the following 15 months. The attrition in support poses important challenges for governments to the use of apps in future pandemics. A potential reason was mistrust in the government's handling of the pandemic.

Indexed as

Contact TracingCOVID-19Mobile ApplicationsState MedicineAdultEnglandFemaleHumansLongitudinal StudiesMaleMiddle AgedPandemicsSARS-CoV-2SmartphoneSurveys and QuestionnairesWalescontact tracing appsCOVID-19infection prevention and controlpublic healthtest and trace

Identifiers

PMID41605498
PMCPMC12895152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.